Tradestie Institutional Equity Comparison Engine

AVDL vs BHC โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

AVDL Overall Edge

AVDL Captures Institutional Edge (2โ€“2 Pillars ยท 6โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Avadel Pharmaceuticals plc Ordinary Share (AVDL) driven by superior Growth & Margin, Momentum & Technical while BHC counters with relative strength in Valuation, Options & Structure. Fundamentally, AVDL trades at 28.8x Forward P/E with 2.5% operating margin (+54.9% YoY revenue) versus BHC at 1.9x Forward P/E and 27.2% operating margin (+9.7% YoY). In options structure, AVDL sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro) against BHC sits in BREAKOUT (100th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner BHC
AVDL 28.8x vs BHC 1.9x Fwd P/E
Growth & Margin Winner AVDL
Op Margin 2.5% vs 27.2% ยท YoY +54.9% vs +9.7%
Momentum & Technical Winner AVDL
1Y +138.1% vs +35.9% ยท 52W Pos 89% vs 83%
Options & Structure Winner BHC
UNCLASSIFIED (<1st %ile IV) vs BREAKOUT (100th %ile IV)
AVDL NASDAQ
Avadel Pharmaceuticals plc Ordinary Share
Pharmaceutical Preparations
$21.64
+0.05% 1D
Market Cap $2.1B
1M Return +0.65%
1Y Return +138.06%
Forward P/E 28.8x
Unified AI Score
62.9 / 100 BUY
Tech 75.0 Fund 60.0 Flow 50.0 Mom 50.0
BHC NYSE
Bausch Health Companies Inc
Pharmaceutical Preparations
$8.22
-3.97% 1D
Market Cap $3.2B
1M Return +26.66%
1Y Return +35.87%
Forward P/E 1.9x
Unified AI Score
44.1 / 100 HOLD
Tech 32.0 Fund 47.0 Flow 70.0 Mom 41.1

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: AVDL +138.06% BHC +35.87% Spread: +6.82 pp (BHC Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
AVDL TTM Op. Margin: 2.5% BHC TTM Op. Margin: 27.2%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AVDL vs BHC. Trailing 12-month operating profitability (AVDL 2.5% vs BHC 27.2%) and valuation multiples (AVDL 28.8x vs BHC 1.9x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: AVDL (6) vs BHC (4)
Institutional Metric AVDL BHC Criterion Row Winner
Market Capitalization Scale $2.1B $3.2B Larger Scale BHC
Trailing P/E Ratio Valuation 16.8x 2.0x Lower Multiple BHC
Forward P/E Ratio Valuation 28.8x 1.9x Lower Multiple BHC
Revenue Growth (YoY) Growth +54.9% +9.7% Higher Growth AVDL
Operating Margin (TTM) Profitability 2.5% 27.2% Higher Margin BHC
Net Profit Margin Profitability -0.1% -7.6% Higher Margin AVDL
Return on Equity (ROE) Capital Efficiency -0.3% -11040.0% Higher ROE AVDL
52-Week Range Position Momentum 89% ($6โ€“$24) 83% ($4โ€“$9) Stronger Trend AVDL
Beta / 30D Volatility Risk Regime 0.14ฮฒ ยท 2% Vol 0.96ฮฒ ยท 111% Vol Lower Realized Risk AVDL
Unified Institutional Score Composite Signal 62.9 / 100 (BUY) 44.1 / 100 (HOLD) Higher Composite AVDL

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full AVDL vs BHC Buy Guide
AVDL UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live AVDL Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
BHC BREAKOUT
78d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 100th %ile
IV Regime Extreme (>80th %ile)
Live BHC Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither AVDL nor BHC registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.